Cite
HARVARD Citation
Liu, S. et al. (2018). Long-term survival follow-up of atezolizumab in combination with platinum-based doublet chemotherapy in patients with advanced non–small-cell lung cancer. European journal of cancer. pp. 114-122. [Online].